SpeakerProfessor Dean Jamison, Professor Emeritus, Global Health Principal Investigator, Disease Control Priorities NetworkDate: 23 August 2016Time: 16.30 – 18.00Venue: Richmond Hotel, NonthaburiNumber of participants: 120 seats availableOrganizer: Health Intervention and Technology Assessment Progr

Integrating Artificial Intelligence (AI) into the health system has the potential to enhance efficiency, accessibility, and overall quality of medical services worldwide. In response to global advancements, Thailand proactively developed the National AI Strategy and Action Plan 2022–2027, which emph

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization's (WHO) Traditional Medicine Strategy 2014-2023 outlin

At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York

68136067MU028L0medical innovation,health technology assessment,health economic evaluation,target product profiles,research and development

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

66183067HM017L0medical innovation,Early HTA,Health Technology

Abstract As COVID-19 ravages the world, many countries are faced with the grim reality of not having enough critical-care resources to go around. Knowing what could be in store, the Thai Ministry of Public Health called for the creation of an explicit protocol to determine how these resources are